PJ of Guinea-Bissau seizes vaccines linked to controversial hepatitis B test

The Judicial Police of Guinea-Bissau seized a batch of hepatitis B vaccines intended for newborns linked to a controversial clinical trial funded by the U.S. The operation aimed to investigate the circumstances surrounding the vaccines and protect public health. The trial, which was suspended due to ethical concerns raised by the WHO, involved excluding some newborns from receiving the vaccine at birth. The U.S. Department of Health funded the trial with $1.6 million, but the Guinean government has postponed the introduction of the vaccine until 2028. The WHO criticized the trial as unethical, emphasizing the importance of vaccinating newborns against hepatitis B.